-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Heterobifunctional Molecules Targeting Epigenetic Mechanisms

Program: Scientific Program
Session: JOINT SESSION: Emerging Therapeutic Strategies Targeting Epigenetic, Transcriptomic, and Metabolic Mechanisms
Hematology Disease Topics & Pathways:
Research, Apoptosis, Translational Research, Genomics, Bioinformatics, Education, Diseases, Lymphoid Malignancies, Computational biology, Myeloid Malignancies, Biological Processes, Molecular biology, Technology and Procedures
Sunday, December 8, 2024, 9:30 AM-11:05 AM

Gerald R. Crabtree, MD

Stanford University, Stanford, CA

Disclosures: Crabtree: Foghorn Therapeutics: Other: Founder and scientific advisor; Shenandoah Therapeutics: Other: Founder and scientific advisor.

See more of: JOINT SESSION: Emerging Therapeutic Strategies Targeting Epigenetic, Transcriptomic, and Metabolic Mechanisms
See more of: Scientific Program
<< Previous Presentation | Next Presentation >>